The prevention and treatment of rejection involve a combination of histological monitoring and immunosuppressive therapy. Regular biopsies are performed to detect early signs of rejection, and immunosuppressive drugs are administered to dampen the immune response. The choice of drugs and their dosages are often guided by histological findings.
